Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Spectranetics has settled its intellectual property dispute with Medtronic, and Medtronic has taken a license to the patent at issue in the litigation. Terms of the settlement agreement were not disclosed.
Subscribe to our email newsletter
John Schulte, Spectranetics’s president and CEO, said: “We are pleased to reach this settlement with Medtronic. This license validates our strong intellectual property position in the area of thrombus management with aspiration catheters.”